Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Cardiovascular risk factors in long‐term followup after orthotopic liver transplantation
1997
Calcineurin Inhibitors FK506 and SDZ ASM 981 Alleviate the Outcome of Focal Cerebral Ischemic/Reperfusion Injury
1999
Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles
1999
Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience
2001
Chimerism of the Transplanted Heart
2002 Standout
Hepatocellular carcinoma
2003 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
1999
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Effective oral administration of tacrolimus in renal transplant recipients
2001
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
1998
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Predictors of renal function following lung or heart-lung transplantation
2002
Viral Dynamics of Hepatitis C Early After Orthotopic Liver Transplantation: Evidence for Rapid Turnover of Serum Virions
1996
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
1996
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
1999
Microchimerism, GVHD, and tolerance in solid organ transplantation
2001
HEPATITIS C VIRUS AND ORGAN TRANSPLANTATION
1996
Hepatocellular carcinoma
2012 Standout
New Immunosuppressive Agents for Maintenance Therapy in Organ Transplantation
1997
Porphyrias
2010 Standout
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
Gout
2009 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Liver Transplantation in European Patients with the Hepatitis B Surface Antigen
1993
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice
2004
Management of Hepatocellular Carcinoma *
2005 Standout
Liver transplantation for chronic viral hepatitis
1995
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
A Risk-Benefit Assessment of Tacrolimus in Transplantation
1995
CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION
1998
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
2010
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
2000
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2
1999
Liver transplantation: Current status and novel approaches to liver replacement
2001
RISK FACTORS OF INVASIVE CANDIDA AND NON-CANDIDA FUNGAL INFECTIONS AFTER LIVER TRANSPLANTATION1
1996
Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment
2003
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
HEPATITIS C VIRUS GENOTYPES IN LIVER TRANSPLANT RECIPIENTS
1997
Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity
2002
Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis
2001
Hepatitis C Viral Infection in Liver Transplantation
1996
Hepatitis C Epidemiology
2000
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Tacrolimus
1997
Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation
1997
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
The Use of Tacrolimus in Pediatric Liver Transplantation
1998
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
2006
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A
1997
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Mycobacterial Infections in Lung Transplant Recipients
1999
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION
2001
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Infection in Organ-Transplant Recipients
1998 Standout
Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients
2002
A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B
2001
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
Hospital-acquired renal insufficiency
2002 Standout
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Sympathetic Neural Mechanisms of Cyclosporine-Induced Hypertension*
1996
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation
2002
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study
2001
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
FUNGAL INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS
1995
A selective role of calcineurin Aα in synaptic depotentiation in hippocampus
1999 StandoutNobel
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Liver disease in erythropoietic protoporphyria: insights and implications for management
2007
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Tacrolimus
2000
Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation.
1995
Hepatitis C infection in the transplant recipient.
1995
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
Therapeutic Monitoring of Tacrolimus
1998
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
Ischemic Cell Death in Brain Neurons
1999 Standout
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins
2002 StandoutNobel
LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS
1999
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Quantitation of hepatitis C virus RNA in liver transplant recipients
1994
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of G. Blumhardt being referenced
The optimal immunosuppressant after liver transplantation according to diagnosis: Cyclosporine A or FK506?
1995
LONG-TERM FOLLOW-UP OF HEPATITIS B VIRUS-INFECTED RECIPIENTS AFTER ORTHOTOPIC LIVER TRANSPLANTATION
1994
Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-α
1991
Hepatitis C Virus Reinfection in Allografts After Orthotopic Liver Transplantation
1992
Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma
1996
Lebertransplantation bei erythrohepatischer Protoporphyrie
2008
COMPARISON OF QUADRUPLE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION WITH ATG OR IL-2 RECEPTOR ANTIBODY
1993
Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations
1994
COMPARISON OF FK506- AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN PRIMARY ORTHOTOPIC LIVER TRANSPLANTATION
1995
Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients
1994
Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine‐based regimen: A controlled, prospective, randomized trial
1995
Selective bowel decontamination effectively prevents gram-negative bacterial infections after liver transplantation.
1990
NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1994
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
1994
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.
1994
Incidence and therapy of cytomegalovirus disease after liver transplantation.
1993
Liver transplantation in HBsAg positive patients.
1990
Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients.
1994
NEUROTOXICITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION
1994
NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1994
Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation.
1994
Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations
1994
Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
1994
Tuberculosis in liver transplant recipients: recurrence after transplantation?
1994
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
1995
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease.
1994